GGrantIndex
Sort

64,565 grants matching drug discovery

Establishment and Characterization of Novel Mutant Mouse Models for the Addiction Research Community

$877,994
Vivek Kumar · Jackson Laboratory · U01 · FY2025 · DA

A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis

$877,993
Cristiana Iosef · Advaita Corporation · R44 · FY2023 · GM

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$877,893
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

BioGRID: An Open Integrated Resource for Biological Interaction Data

$877,795
Michael David Tyers · Sinai Health System · R01 · FY2014 · OD

BioGRID: An Open Integrated Resource for Biological Interaction Data

$877,795
Michael David Tyers · Sinai Health System · R01 · FY2012 · OD

Discovery and optimization of ApoE4 correctors for the treatment of Alzheimer's Disease

$877,636
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AG

Orbitrap Elite High-Resolution Mass Spectrometer for Proteomics and Metabolomics

$877,433
David H Hawke · University Of Tx Md Anderson Can Ctr · S10 · FY2013 · OD

GenePattern and GenePattern Notebook: Integrative 'Omic Analysis for Cancer Research

$877,010
Jill P. Mesirov · University Of California, San Diego · U24 · FY2024 · CA

of Natural Product based Drugs and Bioenergetic Materials from Costa Rican Biota

$876,990
David H Sherman · University Of Michigan At Ann Arbor · U01 · FY2009 · TW

Basic Research Support for the CCR

$876,849
Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria

$876,838
Thomas G Bernhardt · Harvard Medical School · U19 · FY2024 · AI

Quantitative and highly versatile chromatin accessibility platform

$876,387
Michael-Christopher Keogh · Epicypher, Inc. · R44 · FY2021 · HG

NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE

$876,342
University Of Virginia Charlottesville · U19 · FY2001 · CA

Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense

$876,181
John N Van Den Anker · Children'S Research Institute · U54 · FY2011 · HD

Pro-Electrophilic Drugs PEDs for Alzheimer's Disease

$876,156
Stuart A Lipton · Scripps Research Institute, The · R56 · FY2021 · AG

SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery

$876,150
Hao Wu · Boston Children'S Hospital · DP1 · FY2016 · HD

DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS

$876,066
Texas Agrilife Research · P01 · FY2003 · AI

Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria

$875,998
Thomas G Bernhardt · Harvard Medical School · U19 · FY2023 · AI

Vascular Barrier Leakage in Inflammation

$875,962
Sarah Y. Yuan · University Of South Florida · R35 · FY2024 · HL

Ceramides as novel drivers of metabolic dysfunction and colorectal cancer

$875,957
Mary Christine Playdon · Utah State Higher Education System--University Of Utah · U01 · FY2025 · CA

Spectrally resolved tomographic small-animal fluorescence imager

$875,689
Richard M. Levenson · Cambridge Research And Instrumentation · R44 · FY2009 · CA

Molecular strategies for early detection and targeting of cancer

$875,675
Tannishtha Reya · University Of California, San Diego · R35 · FY2019 · CA

Understanding Mechanisms and Sex-Differences in Visceral Pain

$875,653
Holly A. Ingraham · University Of California, San Francisco · R01 · FY2023 · DK

CANCER DRUG DISCOVERY: CELL CYCLE CONTROL TARGETS

$875,425
University Of South Florida · P01 · FY2000 · CA

Structural Biology Core

$875,099
Karson Putt · Indiana University Indianapolis · U54 · FY2022 · AG